ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

07 نوفمبر 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

29 أكتوبر 2024 16:10:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Set to Join S&P SmallCap 600 Index

17 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference

10 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility

14 أغسطس 2024 08:59:22 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

08 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update

09 مايو 2024 16:05:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024

02 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

11 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces CFO Transition

28 فبراير 2024 16:10:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 يناير 2024 07:00:01 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 ديسمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 ديسمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 نوفمبر 2023 16:05:01 بحسب Nasdaq GlobeNewswire